Canaan Partners Xi LLC Tyra Biosciences, Inc. Transaction History
Canaan Partners Xi LLC
- $106 Million
- Q3 2024
A detailed history of Canaan Partners Xi LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Canaan Partners Xi LLC holds 4,409,991 shares of TYRA stock, worth $87.7 Million. This represents 97.89% of its overall portfolio holdings.
Number of Shares
4,409,991
Previous 4,409,991
-0.0%
Holding current value
$87.7 Million
Previous $70.5 Million
47.03%
% of portfolio
97.89%
Previous 85.38%
Shares
1 transactions
Others Institutions Holding TYRA
# of Institutions
80Shares Held
43.4MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA10.4MShares$207 Million2.51% of portfolio
-
Boxer Capital, LLC San Diego, CA6.45MShares$128 Million5.73% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$92.7 Million2.28% of portfolio
-
Nextech Invest Ag4.06MShares$80.7 Million12.24% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA1.99MShares$39.6 Million4.76% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $835M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...